Gefitinib Market Insights Video

According to Cognitive Market Research, the global gefitinib market size is USD 1541.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 616.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 462.36 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 354.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 77.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 30.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
• The 30 tables/box held the highest gefitinib market revenue share in 2024.